LianBio announces terms for IPO next week; NIH and White House officials discuss hypothetical bio-med research agency
LianBio, a biotech that has operations in both the US and China, announced the terms yesterday for its initial public offering …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
